Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Tuesday, September 30

4:10 PM - 4:20 PM PT

342 - Application of Polyethylene Glycol (PEG) Hydrogel in Radical Concurrent Chemoradiotherapy for Cervical Cancer to Prevent Radiation-Induced Rectal Injury: A Multicenter, Randomized, Parallel-Controlled
Speaker: Yan, Junfang, MD - Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College., Beijing, Beijing
4:10 PM - 4:20 PM PT

347 - Differential Prognostic Impact of Distant and Locoregional Recurrence on Survival in Surgically Resected Pathologic N2 NSCLC: Multicenter Dynamic Prediction with Landmark Model
Speaker: Ma, Zeliang, MD - Mayo Clinic Rochester, Rochester, MN
4:15 PM - 4:20 PM PT

1062 - Multicenter Retrospective Analysis of the Safety and Efficacy of Sacituzumab Govitecan Combined with Radiotherapy: The French ATTENTION Study
Speaker: Alati, Aurelia, MD - European Georges Pompidou University Hospital, Paris
4:15 PM - 4:25 PM PT

1067 - Toxicity and Clinical Outcomes of Proton vs. Photon Volumetric Modulated Arc Therapy Craniospinal Irradiation for Solid Tumor Leptomeningeal Carcinomatosis
Speaker: Lamanilao, Gene, MD, MS, BS - University of California San Diego, La Jolla, CA
4:15 PM - 4:20 PM PT

1074 - Implications on Radiation Treatment Planning of 18F-Fluciclovine PET/CT in Patients with Biochemical Recurrence of Prostate Cancer and a Negative PSMA PET/CT
Speaker: Eakin, Adam, MD - Oregon Health and Science University, Portland, OR
4:20 PM - 4:25 PM PT

1063 - Dose-Volume Predictors for Radiation Esophagitis in Breast Cancer Patients Undergoing Conventional Fractionated Regional Nodal Radiotherapy: A Prospective Study
Speaker: Wang, Dan-Qiong, MD - National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Acade, ???, Beijing
4:20 PM - 4:25 PM PT

1075 - Analysis on the Predictive Power of PSA-Nadir <0.1 ng/ml after Salvage Radiotherapy for PSA-Recurrence after Radical Prostatectomy - Subanalysis of the Phase-III Dose Escalation SAKK 09/10 Study and C
Speaker: Wiegel, Thomas, MD - University Hospital Ulm, Ulm, Baden-Wurt
4:20 PM - 4:30 PM PT

343 - Phase 3 Study of Pembrolizumab (Pembro) + Adjuvant Chemotherapy (CT) ± Radiotherapy (RT) for Newly Diagnosed, High-Risk Endometrial Cancer (EC): Exploratory Analysis of Disease-Specific-Free Survival
Speaker: Mayadev, Jyoti, MD - University of California, San Diego Medical Center, San Diego, CA
4:20 PM - 4:30 PM PT

348 - Impact of AI-Based Coronary Artery Calcium (CAC) Scores and Heart Dose on Survival in Locally-Advanced Non-Small-Cell Lung Cancer (LA-NSCLC): A Secondary Analysis of RTOG 0617
Speaker: Haldar, Nilanjan, MD, BS - Thomas Jefferson University, Philadelphia, PA
4:25 PM - 4:30 PM PT

1064 - Dosimetric Correlates of Acute Toxicities for Hypofractionated Whole-Breast Irradiation, A Single Institution Retrospective Investigation: Is There a Need to Update the Guidelines?
Speaker: Dumane, Vishruta, PhD - Icahn School of Medicine at Mount Sinai, New York, NY
4:25 PM - 4:35 PM PT

1068 - Results of a Randomized Phase 2 Study of a Novel Superoxide Dismutase Mimetic in Patients with Multiple Brain Metastases undergoing Whole-Brain Radiotherapy
Speaker: Kirkpatrick, John, MD, PhD, FASTRO - Duke University Medical Center, Chapel Hill, North Carolina
4:25 PM - 4:30 PM PT

1076 - Early Results from a Randomized Phase II Trial Testing Apalutamide and Stereotactic Body Radiation Therapy for Low-Burden Mhspc (NCT05717660)
Speaker: Loi, Mauro, MD - Azienda Ospedaliera Universitaria Careggi, Florence, Tuscany